Feature | August 21, 2012

High-quality dosimetry training is available to the international radiotherapy community at the new ICC in Germany

Training at the new International Competence Center.


August 21, 2012 — IBA (Ion Beam Applications S.A.) officially opened its International Competence Center (ICC) in July in Nuremberg, Germany. The ICC provides high-level practical training to promote safer radiation therapy to healthcare professionals, using the latest software and hardware radiation treatment and specialist measurement tools.

Exceptional accuracy and reliability is necessary to deliver safe and effective radiation treatment. Recent developments to radiation delivery platforms and other new technologies have allowed greater control of radiation dose distribution and the delivery of a higher, more targeted, radiation dose to tumors. However, as technology becomes more complex, the risk of errors and the adverse effects of radiation also increase.

Dosimetry training at the ICC will provide healthcare professionals with essential knowledge and skills necessary to minimize radiation errors and maximize accuracy and efficiency in their daily checks, contributing to significantly reducing treatment downtime.

“The idea behind the establishment of the ICC is to improve cancer treatment outcomes by providing high-quality dosimetry training to healthcare professionals involved in the planning and delivery of radiation therapy," said Rob Plompen, president of IBA Dosimetry. "With the ICC, we have created an environment that promotes an international exchange of knowledge and experiences among those involved in measuring radiation dosage. Our comprehensive training courses will include topics such as efficient and effective linear accelerator (linac) and RTPS commissioning, verifying complex intensity-modulated radiation therapy (IMRT) and rotational treatments in 2-D and 3-D, and regulatory and quality assurance matters in radiation therapy.”

For more information: www.iba-group.com


Related Content

News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Dec. 1, 2025 — GE HealthCare has unveiled the Allia Moveo,1 an image guiding solution designed to enhance mobility and ...

Time December 02, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Lung Imaging

Nov. 3, 2025 — RevealDx, a leader in the characterization of lung nodules, has introduced MDR Certification of RevealAI ...

Time November 07, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Subscribe Now